The global smoking cessation and nicotine de-addiction products market was valued at $19,965.28million in 2021, and is estimated to reach $54,708.87 million by 2031, growing at a CAGR of 10.6% from 2022 to 2031.
Smoking cessation or nicotine de-addiction means the act of stopping tobacco use. Tobacco contains alkaloid compound called nicotine, which causes addiction toward cigarettes and other smoking products. The addiction is caused by releasing neurotransmitters such as glutamate, dopamine, and gamma-aminobutyric acid (GABA). Furthermore, cigarette and tobacco addicts can be better treated with smoking cessation products.
Major factors that drive growth of the smoking cessation and nicotine de-addiction products market is the rise in number of populations who are quitting smoking and ant-smoking initiatives and campaigns by various governments and private organizations. Furthermore, shift of adults toward e-cigarettes also serves as a growing factor for the market. The Centers for Disease Control and Prevention (CDC) stated that, 60.2% of youth who used tobacco products have stopped using all these products for one day or longer as they were willing to quit tobacco in 2021.
The World Health Organization (WHO) launched a year-long global campaign for World No Tobacco Day 2021, “Commit to Quit" challenge and published more than 100 reasons to quit tobacco to mark start of the campaign. In addition, free initiatives by governments, increase in consciousness and education among young population and smokers, and approved smoking cessation drugs in the market are leveraging smoking cessation and nicotine de-addiction products market. However, high cost of therapies can lead to decrease in purchase of these products, which can ultimately hinder growth of the market.
Key market players are investing in research and development of innovative solutions and therapies for smoking cessation. One such innovation is e-cigarettes. Normal cigarettes consist 90% tobacco, which is increasing demand of e-cigarette that is a battery-powered device that generates an inhaled aerosol and have very less tobacco.
According to the Centers for Disease Control and Prevention (CDC), cigarette smoking also causes various chronic disease such as lung cancer and chronic obstructive pulmonary disease (COPD). As smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans, rise in number of chronic ailments propel major companies to introduce innovative nicotine replacement therapy products further driving demand for nicotine replacement therapy products.
The global smoking cessation and nicotine de-addiction products market is segmented on the basis of product, form, distribution channel, and region. On the basis of product, the market is categorized into nicotine replacement therapy products, drug therapy, and e-cigarettes. The nicotine replacement therapy segment is further divided into nicotine lozenges, nicotine gums, nicotine sprays, and nicotine inhalers. By form, the market is divided into gum, inhalers, tablets, and others. By distribution channel, it is segmented into hospital pharmacies, online providers, and drug stores and retail pharmacies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
Major players profiled in the report are British American Tobacco Inc., 22nd Century group Inc., Cipla Ltd., Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline PLC (Haleon), Imperial Brands Plc. (Fontem Ventures), Johnson and Johnson (McNeil Consumer Health), Njoy Company, Pfizer Inc., Perrigo Company Plc., Rusan Pharma, and Zydus Cadila.
Smoking cessation or nicotine de-addiction means the act of stopping tobacco use. Tobacco contains alkaloid compound called nicotine, which causes addiction toward cigarettes and other smoking products. The addiction is caused by releasing neurotransmitters such as glutamate, dopamine, and gamma-aminobutyric acid (GABA). Furthermore, cigarette and tobacco addicts can be better treated with smoking cessation products.
Major factors that drive growth of the smoking cessation and nicotine de-addiction products market is the rise in number of populations who are quitting smoking and ant-smoking initiatives and campaigns by various governments and private organizations. Furthermore, shift of adults toward e-cigarettes also serves as a growing factor for the market. The Centers for Disease Control and Prevention (CDC) stated that, 60.2% of youth who used tobacco products have stopped using all these products for one day or longer as they were willing to quit tobacco in 2021.
The World Health Organization (WHO) launched a year-long global campaign for World No Tobacco Day 2021, “Commit to Quit" challenge and published more than 100 reasons to quit tobacco to mark start of the campaign. In addition, free initiatives by governments, increase in consciousness and education among young population and smokers, and approved smoking cessation drugs in the market are leveraging smoking cessation and nicotine de-addiction products market. However, high cost of therapies can lead to decrease in purchase of these products, which can ultimately hinder growth of the market.
Key market players are investing in research and development of innovative solutions and therapies for smoking cessation. One such innovation is e-cigarettes. Normal cigarettes consist 90% tobacco, which is increasing demand of e-cigarette that is a battery-powered device that generates an inhaled aerosol and have very less tobacco.
According to the Centers for Disease Control and Prevention (CDC), cigarette smoking also causes various chronic disease such as lung cancer and chronic obstructive pulmonary disease (COPD). As smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans, rise in number of chronic ailments propel major companies to introduce innovative nicotine replacement therapy products further driving demand for nicotine replacement therapy products.
The global smoking cessation and nicotine de-addiction products market is segmented on the basis of product, form, distribution channel, and region. On the basis of product, the market is categorized into nicotine replacement therapy products, drug therapy, and e-cigarettes. The nicotine replacement therapy segment is further divided into nicotine lozenges, nicotine gums, nicotine sprays, and nicotine inhalers. By form, the market is divided into gum, inhalers, tablets, and others. By distribution channel, it is segmented into hospital pharmacies, online providers, and drug stores and retail pharmacies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
Major players profiled in the report are British American Tobacco Inc., 22nd Century group Inc., Cipla Ltd., Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline PLC (Haleon), Imperial Brands Plc. (Fontem Ventures), Johnson and Johnson (McNeil Consumer Health), Njoy Company, Pfizer Inc., Perrigo Company Plc., Rusan Pharma, and Zydus Cadila.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the smoking cessation and nicotine de-addiction products market analysis from 2021 to 2031 to identify the prevailing smoking cessation and nicotine de-addiction products market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the smoking cessation and nicotine de-addiction products market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global smoking cessation and nicotine de-addiction products market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Nicotine Replacement Therapy Products
By Type
- Nicotine Lozenges
- Nicotine Gums
- Nicotine Sprays
- Nicotine Inhalers
- Drug Therapy
- E-cigarettes
By Form
- Gum
- Inhaler
- Tablet
- Others
By Distribution Channel
- Hospital Pharmacies
- Online Provider
- Drug stores and Retail Pharmacies
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- British American Tobacco Plc
- 22nd Century group Inc.
- Cipla Ltd.
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline Plc.
- Imperial Brands Plc.
- Johnson and Johnson Inc
- Njoy Company
- Perrigo Company Plc.
- Pfizer Inc.
- Zydus Cadila, Inc.
- Rusan Pharma Ltd
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Nicotine Replacement Therapy Products
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
4.2.4.1 Nicotine Lozenges Market size and forecast, by region
4.2.4.2 Nicotine Gums Market size and forecast, by region
4.2.4.3 Nicotine Sprays Market size and forecast, by region
4.2.4.4 Nicotine Inhalers Market size and forecast, by region
4.3 Drug Therapy
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 E-cigarettes
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY FORM
5.1 Overview
5.1.1 Market size and forecast
5.2 Gum
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Inhaler
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Tablet
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Online Provider
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 DrU.S.ores and Retail Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.2.1 North America Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.2.3 North America Market size and forecast, by Form
7.2.4 North America Market size and forecast, by Distribution Channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Form
7.2.5.1.3 Market size and forecast, by Distribution Channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Form
7.2.5.2.3 Market size and forecast, by Distribution Channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Form
7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.2.1 Europe Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.3.3 Europe Market size and forecast, by Form
7.3.4 Europe Market size and forecast, by Distribution Channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Form
7.3.5.1.3 Market size and forecast, by Distribution Channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Form
7.3.5.2.3 Market size and forecast, by Distribution Channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Form
7.3.5.3.3 Market size and forecast, by Distribution Channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Form
7.3.5.4.3 Market size and forecast, by Distribution Channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Form
7.3.5.5.3 Market size and forecast, by Distribution Channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Form
7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.2.1 Asia-Pacific Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.4.3 Asia-Pacific Market size and forecast, by Form
7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Form
7.4.5.1.3 Market size and forecast, by Distribution Channel
7.4.5.2 China
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Form
7.4.5.2.3 Market size and forecast, by Distribution Channel
7.4.5.3 Australia
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Form
7.4.5.3.3 Market size and forecast, by Distribution Channel
7.4.5.4 India
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Form
7.4.5.4.3 Market size and forecast, by Distribution Channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Form
7.4.5.5.3 Market size and forecast, by Distribution Channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Form
7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.2.1 LAMEA Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market by Type
7.5.3 LAMEA Market size and forecast, by Form
7.5.4 LAMEA Market size and forecast, by Distribution Channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Form
7.5.5.1.3 Market size and forecast, by Distribution Channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Form
7.5.5.2.3 Market size and forecast, by Distribution Channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Form
7.5.5.3.3 Market size and forecast, by Distribution Channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Form
7.5.5.4.3 Market size and forecast, by Distribution Channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 British American Tobacco Plc
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 22nd Century group Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cipla Ltd.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Dr. Reddy’s Laboratories Ltd.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 GlaxoSmithKline Plc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Imperial Brands Plc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Johnson and Johnson Inc
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Njoy Company
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Perrigo Company Plc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Pfizer Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 Zydus Cadila, Inc.
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments
9.12 Rusan Pharma Ltd
9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Operating business segments
9.12.4 Product portfolio
9.12.5 Business performance
9.12.6 Key strategic moves and developments
List of Tables
Table 1. Global Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 2. Smoking Cessation and Nicotine De-Addiction Products Market, for Nicotine Replacement Therapy Products, by Region, 2021-2031 ($Million)
Table 3. Smoking Cessation and Nicotine De-Addiction Products Market for Nicotine Replacement Therapy Products, by Country, 2021-2031 ($Million)
Table 4. Global Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market, by Type, 2021-2031 ($Million)
Table 5. Smoking Cessation and Nicotine De-Addiction Products Market, for Nicotine Lozenges, by Region, 2021-2031 ($Million)
Table 6. Smoking Cessation and Nicotine De-Addiction Products Market, for Nicotine Gums, by Region, 2021-2031 ($Million)
Table 7. Smoking Cessation and Nicotine De-Addiction Products Market, for Nicotine Sprays, by Region, 2021-2031 ($Million)
Table 8. Smoking Cessation and Nicotine De-Addiction Products Market, for Nicotine Inhalers, by Region, 2021-2031 ($Million)
Table 9. Smoking Cessation and Nicotine De-Addiction Products Market, for Drug Therapy, by Region, 2021-2031 ($Million)
Table 10. Smoking Cessation and Nicotine De-Addiction Products Market for Drug Therapy, by Country, 2021-2031 ($Million)
Table 11. Smoking Cessation and Nicotine De-Addiction Products Market, for E-Cigarettes, by Region, 2021-2031 ($Million)
Table 12. Smoking Cessation and Nicotine De-Addiction Products Market for E-Cigarettes, by Country, 2021-2031 ($Million)
Table 13. Global Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 14. Smoking Cessation and Nicotine De-Addiction Products Market, for Gum, by Region, 2021-2031 ($Million)
Table 15. Smoking Cessation and Nicotine De-Addiction Products Market for Gum, by Country, 2021-2031 ($Million)
Table 16. Smoking Cessation and Nicotine De-Addiction Products Market, for Inhaler, by Region, 2021-2031 ($Million)
Table 17. Smoking Cessation and Nicotine De-Addiction Products Market for Inhaler, by Country, 2021-2031 ($Million)
Table 18. Smoking Cessation and Nicotine De-Addiction Products Market, for Tablet, by Region, 2021-2031 ($Million)
Table 19. Smoking Cessation and Nicotine De-Addiction Products Market for Tablet, by Country, 2021-2031 ($Million)
Table 20. Smoking Cessation and Nicotine De-Addiction Products Market, for Others, by Region, 2021-2031 ($Million)
Table 21. Smoking Cessation and Nicotine De-Addiction Products Market for Others, by Country, 2021-2031 ($Million)
Table 22. Global Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 23. Smoking Cessation and Nicotine De-Addiction Products Market, for Hospital Pharmacies, by Region, 2021-2031 ($Million)
Table 24. Smoking Cessation and Nicotine De-Addiction Products Market for Hospital Pharmacies, by Country, 2021-2031 ($Million)
Table 25. Smoking Cessation and Nicotine De-Addiction Products Market, for Online Provider, by Region, 2021-2031 ($Million)
Table 26. Smoking Cessation and Nicotine De-Addiction Products Market for Online Provider, by Country, 2021-2031 ($Million)
Table 27. Smoking Cessation and Nicotine De-Addiction Products Market, for DrU.S.ores and Retail Pharmacies, by Region, 2021-2031 ($Million)
Table 28. Smoking Cessation and Nicotine De-Addiction Products Market for DrU.S.ores and Retail Pharmacies, by Country, 2021-2031 ($Million)
Table 29. Smoking Cessation and Nicotine De-Addiction Products Market, by Region, 2021-2031 ($Million)
Table 30. North America Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 31. North America Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market, by Type, 2021-2031 ($Million)
Table 32. North America Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 33. North America Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 34. North America Smoking Cessation and Nicotine De-Addiction Products Market, by Country, 2021-2031 ($Million)
Table 35. U.S. Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 36. U.S. Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 37. U.S. Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 38. Canada Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 39. Canada Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 40. Canada Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 41. Mexico Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 42. Mexico Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 43. Mexico Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 44. Europe Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 45. Europe Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market, by Type, 2021-2031 ($Million)
Table 46. Europe Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 47. Europe Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 48. Europe Smoking Cessation and Nicotine De-Addiction Products Market, by Country, 2021-2031 ($Million)
Table 49. Germany Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 50. Germany Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 51. Germany Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 52. France Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 53. France Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 54. France Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 55. U.S.oking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 56. U.S.oking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 57. U.S.oking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 58. Italy Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 59. Italy Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 60. Italy Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 61. Spain Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 62. Spain Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 63. Spain Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 64. Rest of Europe Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 65. Rest of Europe Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 66. Rest of Europe Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 67. Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 68. Asia-Pacific Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market, by Type, 2021-2031 ($Million)
Table 69. Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 70. Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 71. Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, by Country, 2021-2031 ($Million)
Table 72. Japan Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 73. Japan Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 74. Japan Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 75. China Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 76. China Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 77. China Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 78. Australia Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 79. Australia Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 80. Australia Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 81. India Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 82. India Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 83. India Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 84. South Korea Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 85. South Korea Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 86. South Korea Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 87. Rest of Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 88. Rest of Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 89. Rest of Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 90. LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 91. LAMEA Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market, by Type, 2021-2031 ($Million)
Table 92. LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 93. LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 94. LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, by Country, 2021-2031 ($Million)
Table 95. Brazil Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 96. Brazil Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 97. Brazil Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 98. Saudi Arabia Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 99. Saudi Arabia Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 100. Saudi Arabia Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 101. South Africa Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 102. South Africa Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 103. South Africa Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 104. Rest of LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, by Product, 2021-2031 ($Million)
Table 105. Rest of LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, by Form, 2021-2031 ($Million)
Table 106. Rest of LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, by Distribution Channel, 2021-2031 ($Million)
Table 107. British American Tobacco PLC: Company Snapshot
Table 108. British American Tobacco PLC: Operating Segments
Table 109. British American Tobacco PLC: Product Portfolio
Table 110. British American Tobacco PLC: Net Sales
Table 111. British American Tobacco PLC: Key Strategies
Table 112. 22Nd Century Group Inc.: Company Snapshot
Table 113. 22Nd Century Group Inc.: Operating Segments
Table 114. 22Nd Century Group Inc.: Product Portfolio
Table 115. 22Nd Century Group Inc.: Net Sales
Table 116. 22Nd Century Group Inc.: Key Strategies
Table 117. Cipla Ltd.: Company Snapshot
Table 118. Cipla Ltd.: Operating Segments
Table 119. Cipla Ltd.: Product Portfolio
Table 120. Cipla Ltd.: Net Sales
Table 121. Cipla Ltd.: Key Strategies
Table 122. Dr. Reddy's Laboratories Ltd.: Company Snapshot
Table 123. Dr. Reddy's Laboratories Ltd.: Operating Segments
Table 124. Dr. Reddy's Laboratories Ltd.: Product Portfolio
Table 125. Dr. Reddy's Laboratories Ltd.: Net Sales
Table 126. Dr. Reddy's Laboratories Ltd.: Key Strategies
Table 127. GlaxoSmithKline PLC.: Company Snapshot
Table 128. GlaxoSmithKline PLC.: Operating Segments
Table 129. GlaxoSmithKline PLC.: Product Portfolio
Table 130. GlaxoSmithKline PLC.: Net Sales
Table 131. GlaxoSmithKline PLC.: Key Strategies
Table 132. Imperial Brands PLC.: Company Snapshot
Table 133. Imperial Brands PLC.: Operating Segments
Table 134. Imperial Brands PLC.: Product Portfolio
Table 135. Imperial Brands PLC.: Net Sales
Table 136. Imperial Brands PLC.: Key Strategies
Table 137. Johnson and Johnson Inc.: Company Snapshot
Table 138. Johnson and Johnson Inc.: Operating Segments
Table 139. Johnson and Johnson Inc.: Product Portfolio
Table 140. Johnson and Johnson Inc.: Net Sales
Table 141. Johnson and Johnson Inc.: Key Strategies
Table 142. Njoy Company: Company Snapshot
Table 143. Njoy Company: Operating Segments
Table 144. Njoy Company: Product Portfolio
Table 145. Njoy Company: Net Sales
Table 146. Njoy Company: Key Strategies
Table 147. Perrigo Company PLC.: Company Snapshot
Table 148. Perrigo Company PLC.: Operating Segments
Table 149. Perrigo Company PLC.: Product Portfolio
Table 150. Perrigo Company PLC.: Net Sales
Table 151. Perrigo Company PLC.: Key Strategies
Table 152. Pfizer Inc.: Company Snapshot
Table 153. Pfizer Inc.: Operating Segments
Table 154. Pfizer Inc.: Product Portfolio
Table 155. Pfizer Inc.: Net Sales
Table 156. Pfizer Inc.: Key Strategies
Table 157. Zydus Cadila, Inc.: Company Snapshot
Table 158. Zydus Cadila, Inc.: Operating Segments
Table 159. Zydus Cadila, Inc.: Product Portfolio
Table 160. Zydus Cadila, Inc.: Net Sales
Table 161. Zydus Cadila, Inc.: Key Strategies
Table 162. Rusan Pharma Ltd.: Company Snapshot
Table 163. Rusan Pharma Ltd.: Operating Segments
Table 164. Rusan Pharma Ltd.: Product Portfolio
Table 165. Rusan Pharma Ltd.: Net Sales
Table 166. Rusan Pharma Ltd.: Key Strategies
List of Figures
Figure 1. Smoking Cessation and Nicotine De-Addiction Products Market Segmentation
Figure 2. Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031
Figure 3. Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Smoking Cessation and Nicotine De-Addiction Products Mark.:Drivers, Restraints and Opportunities
Figure 12. Smoking Cessation and Nicotine De-Addiction Products Market, By Product, 2021(%)
Figure 13. Comparative Share Analysis of Nicotine Replacement Therapy Products Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 14. Comparative Share Analysis of Drug Therapy Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 15. Comparative Share Analysis of E-Cigarettes Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 16. Smoking Cessation and Nicotine De-Addiction Products Market, By Form, 2021(%)
Figure 17. Comparative Share Analysis of Gum Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 18. Comparative Share Analysis of Inhaler Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 19. Comparative Share Analysis of Tablet Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 20. Comparative Share Analysis of Others Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 21. Smoking Cessation and Nicotine De-Addiction Products Market, By Distribution Channel, 2021(%)
Figure 22. Comparative Share Analysis of Hospital Pharmacies Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 23. Comparative Share Analysis of Online Provider Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 24. Comparative Share Analysis of Drug Stores and Retail Pharmacies Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031(%)
Figure 25. Smoking Cessation and Nicotine De-Addiction Products Market by Region, 2021
Figure 26. U.S. Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 27. Canada Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 28. Mexico Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 29. Germany Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 30. France Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 31. Uk Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 32. Italy Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 33. Spain Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 34. Rest of Europe Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 35. Japan Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 36. China Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 37. Australia Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 38. India Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 39. South Korea Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 40. Rest of Asia-Pacific Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 41. Brazil Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 42. Saudi Arabia Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 43. South Africa Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 44. Rest of LAMEA Smoking Cessation and Nicotine De-Addiction Products Market, 2021-2031($Million)
Figure 45. Top Winning Strategies, by Year
Figure 46. Top Winning Strategies, by Development
Figure 47. Top Winning Strategies, by Company
Figure 48. Product Mapping of Top 10 Players
Figure 49. Competitive Dashboard
Figure 50. Competitive Heatmap of Top 10 Key Players
Figure 51. British American Tobacco pl.: Net Sales, ($Million)
Figure 52. 22Nd Century Group Inc.: Net Sales, ($Million)
Figure 53. Cipla Ltd.: Net Sales, ($Million)
Figure 54. Dr. Reddy’S Laboratories Ltd.: Net Sales, ($Million)
Figure 55. GlaxoSmithKline plc.: Net Sales, ($Million)
Figure 56. Imperial Brands plc.: Net Sales, ($Million)
Figure 57. Johnson and Johnson In.: Net Sales, ($Million)
Figure 58. Njoy Compan.: Net Sales, ($Million)
Figure 59. Perrigo Company plc.: Net Sales, ($Million)
Figure 60. Pfizer Inc.: Net Sales, ($Million)
Figure 61. Zydus Cadila, Inc.: Net Sales, ($Million)
Figure 62. Rusan Pharma Lt.: Net Sales, ($Million)
Executive Summary
According to the report, “Smoking Cessation and Nicotine De-Addiction Products Market," the Smoking Cessation and Nicotine De-Addiction Products Market size was valued at $20 billion in 2021, and is estimated to reach $54.7 billion by 2031, growing at a CAGR of 10.6% from 2022 to 2031.Smoking cessation refers to the act of quitting smoking. Nicotine, an alkaloid, makes people dependent on cigarettes and other smoking products. There are more than 7000 dangerous chemicals found in tobacco smoking that cause or exacerbate pre-existing illnesses such as diabetes, weakened immunity, respiratory illnesses, lungs cancer, cardiovascular issues, cataract, macular degeneration, eyesight loss, tooth or gum diseases, and impotence or infertility.
To overcome this condition, there are many anti-smoking campaigns organized by governments, which further leads to increase in awareness among people about smoking cessation. In addition, growth in number of smokers, smoking-related respiratory illnesses, growth in public anti-smoking campaigns, and expanding awareness of smoking cessation therapies contribute toward the global smoking cessation and nicotine de-addiction products industry.
In addition, every business has been impacted by the unmatched worldwide public health crisis known as COVID-19, and the long-term impacts are expected to have an influence on industry growth during the forecast period. Several changes in consumer demand and behavior, buying habits, supply chain redirection, and significant government initiatives have been seen around the globe. The COVID-19 pandemic has changed the patterns of smoking, other substance uses and other health-related behaviors of the smokers. Smokers in several nations have increased their tobacco consumption since the pandemic. On the other hand, there has also been a surge in interest in stopping, quit attempts, and successful cessation rates, which further caused prevalence of factors affecting growth of the smoking cessation and nicotine de-addiction products market size.
By product type, the market is segmented into nicotine replacement therapy products, drug therapy, and e-cigarettes. The e-cigarettes segment generated maximum revenue in 2021. The nicotine replacement therapy products segment is expected to grow at the highest CAGR during the forecast period, owing to rise in adoption of quit smoking challenges by large population, cost-effectiveness, improved innovation, and various product launches.
Depending on the form, the market is divided into gum, inhaler, tablet and others. The others segment further includes lozenges and sprays. In this smoking cessation and nicotine de-addiction products market trends the gum segment dominated the market in 2021, and is expected to be the fastest growing segment during smoking cessation and nicotine de-addiction products market forecast period, owing to rise in demand for nicotine replacement therapy products, innovations by key market players, and rising awareness about quitting smoking.
Depending on distribution channel, the market is divided into hospital pharmacies, online providers, and drug stores and retail pharmacies. The drug stores and retail pharmacies segment dominated the market in 2021, and the online providers segment is expected to grow at the fastest CAGR, during the forecast period, owing to rise in digitalization, ease of purchase, faster delivery of products and accessibility of smartphones.
North America accounted for majority of the global smoking cessation and nicotine de-addiction products market share in 2021. On the other hand, Asia-Pacific is anticipated to dominate the smoking cessation and nicotine de-addiction products industry during the forecast period. This is attributed to increase in awareness regarding harmful effects of smoking that has forced many people in the region to quit smoking, which, in turn, propels the smoking cessation and nicotine de-addiction market. However, Asia-Pacific is anticipated to witness notable growth, owing to large prevalence of tobacco users in this region and rising rate of users to quit tobacco and smoking.
Key Findings of the Study
- By product type, in smoking cessation market the, e-cigarettes segment was the highest contributor to the market in 2021.
- By form, the gum segment was the highest contributor to the smoking cessation and nicotine de-addiction products market analysis in 2021.
- Depending on distribution channel, the drug stores and retail pharmacies segment was highest contributor in 2021, and the online providers segment is expected to grow at the highest CAGR during the forecast period.
- Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- British American Tobacco Plc
- 22nd Century group Inc.
- Cipla Ltd.
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline Plc.
- Imperial Brands Plc.
- Johnson and Johnson Inc
- Njoy Company
- Perrigo Company Plc.
- Pfizer Inc.
- Zydus Cadila, Inc.
- Rusan Pharma Ltd
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 310 |
| Published | September 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 19975.91 million |
| Forecasted Market Value ( USD | $ 54708.87 million |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
